黑料网

July 10, 2024
The Centers for Medicare and Medicaid Services (CMS) released the calendar year 2025 Medicare Physician Fee Schedule (MPFS) with July 10. The agency and to policies for the Medicare Shared Saving Program, Prescription Drug Inflation Rebate Program and provider overpayments.

The 黑料网® (黑料网®) created an  of all provisions of the MPFS proposed rule that have a direct impact on imaging practices.

CMS estimates a 2025 conversion factor of $32.3562 compared to the 2024 conversion factor of $33.2875. This was calculated by removing the 1.25% provided by the Consolidated Appropriations Act of 2023 that applied to services furnished Jan. 1 through March 8, 2024, and a 2.93% payment increase provided by the Consolidated Appropriations Act of 2024 that applied to services furnished March 9, 2024, through Dec. 31. CMS then applied a positive 0.05% budget neutrality adjustment.

CMS estimates an overall impact of the MPFS proposed changes to radiology, nuclear medicine and radiation oncology to be a neutral 0%, while interventional radiology would see an aggregate decrease of 2% if the provisions within the proposed rule are finalized.

The overall conversion factor reduction once again demonstrates that the current Medicare payment system is not sustainable. 黑料网 will continue to work with Congress to encourage substantive changes to the Medicare physician payment system to ensure patients continue to have access to high quality care.

In addition to payment provisions, the rule includes a proposal to cover screening CT colonography (CTC) for colorectal cancer for Medicare beneficiaries. The 黑料网 has long advocated for Medicare coverage of screening CTC and applauds the proposal.

A detailed summary will be provided in the coming weeks. For questions about the proposed rule, contact Katie Keysor, 黑料网 Senior Director of Economic Policy.

Related 黑料网 News

  • 黑料网 Presents to FDA on Oversight Considerations for GenAI Medical Devices

    The 黑料网庐 presented at the U.S. FDA Digital Health Advisory Committee meeting 鈥淭otal Product Lifecycle Considerations for Generative AI-Enabled Devices.鈥 Bernardo Bizzo, MD, PhD, 黑料网 Data Science Institute庐 Associate Chief Science Officer, represented the College at the meeting.

    Read more
  • 黑料网 DSI Releases 2 New Non-Interpretive Reading Room Use Cases

    use cases, artificial intelligence, reading room

    Read more
  • Direct Supervision for Contrast Studies

    We recommend that sites follow the 黑料网 CT and MR Accreditation requirements for onsite supervision of contrast administration and management.

    Read more